In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

The in vitro activities of rufloxacin and its metabolite, MF 922, were compared with those of ofloxacin, ciprofloxacin, erythromycin, and minocycline against Mycoplasma pneumoniae, Mycoplasma hominis, Mycoplasma fermentans, and Ureaplasma urealyticum. Rufloxacin, MF 922, and ciprofloxacin shared sim...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Furneri, P M, Bisignano, G, Cerniglia, G, Nicoletti, G, Cesana, M, Tempera, G
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1994
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188257/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7872762/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.11.2651
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!